Article ID Journal Published Year Pages File Type
10484835 Value in Health 2015 9 Pages PDF
Abstract
Administering NAC before surgery to patients in the high-risk subgroup was cost-effective at “normal” levels of willingness to pay, but not for the overall sample or for patients in the non-high-risk subgroup.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer
Authors
, , , , , , ,